More than 100 million American adults have obesity and more than 20 million adults have severe obesity, U.S. figures show.

Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...

It helps improve blood sugar in adults with type 2 diabetes ... Pro Tip Even modest weight loss can reduce your risk of developing chronic diseases related to obesity, such as type 2 diabetes ...

Heading into a gluttonous time of year in the U.S. with Halloween, Thanksgiving and Christmas on deck, it might be a bad time for Americans to find out their obesity rates continue to climb.

Obesity is high and holding steady in the U.S. About 4 in 10 Americans have obesity overall and about 1 in 10 have severe ...

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

receptor agonist indicated as an adjunct to a reduced diet and increased exercise for chronic weight management in overweight or generally obese adults with at least one weight-related condition such ...

A new medical study published this month suggests yes — with some key factors to keep in mind. Ozempic’s long-term impact.

All weight loss medications are not created equal ... receptor agonist approved for chronic weight management in adults and children 12 years and older meeting BMI criteria.